Inventor
HRUBY VICTOR J
US35 patents
⚠️ This page may combine multiple inventors who share the name “HRUBY VICTOR J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV ARIZONA
16 patentsUS5731408AMar 24, 1998
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
UNIV ARIZONA184 citations99
US9814755B2Nov 14, 2017
Methods for the treatment of depression and anxiety
UNIV ARIZONA7 citations83
US9821023B2Nov 21, 2017
Methods for the treatment of central nervous system (CNS) disorders and mood disorders
UNIV ARIZONA7 citations82
US10617681B2Apr 14, 2020
1-arylalkyl-4-acylaminopiperidine compounds
UNIV ARIZONA1 citations69
US9539301B2Jan 10, 2017
Melanotropin ligands for skin care
UNIV ARIZONA3 citations69
US5326751AJul 5, 1994
Enkephalin analogs
UNIV ARIZONA15 citations67
US12440570B2Oct 14, 2025
Conjugation of MCR1 ligand with cytotoxic drugs for treating skin cancer
UNIV ARIZONA0 citations62
US11124542B2Sep 21, 2021
Modulators of melanocortin receptors
UNIV ARIZONA0 citations61
US11440885B2Sep 13, 2022
Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same
UNIV ARIZONA0 citations58
US11970521B2Apr 30, 2024
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
UNIV ARIZONA0 citations56
US11542302B2Jan 3, 2023
Modulators of melanocortin receptors for the treatment of depression and anxiety
UNIV ARIZONA0 citations56
US11141452B2Oct 12, 2021
Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating pain
UNIV ARIZONA0 citations52
US10550157B2Feb 4, 2020
Compositions and methods for treating central nervous system (CNS) disorders and mood disorders
UNIV ARIZONA0 citations51
US10653743B2May 19, 2020
Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
UNIV ARIZONA0 citations45
US10428115B2Oct 1, 2019
Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain
UNIV ARIZONA0 citations41
US10188704B2Jan 29, 2019
Enhanced melanoma cancer prevention by novel melanotropins
UNIV ARIZONA0 citations40
UNIVERSITY PATENTS INC
5 patentsUS4485039ANov 27, 1984
Synthetic analogues of α-melanotropin
UNIVERSITY PATENTS INC61 citations96
US4866038ASep 12, 1989
Method of stimulating integumental melanocytes by topical application of analogs of alpha-msh
UNIVERSITY PATENTS INC107 citations94
US5049547ASep 17, 1991
Composition for stimulating integumental melanocytes
UNIVERSITY PATENTS INC52 citations90
US4457864AJul 3, 1984
Synthetic analogues of α-melanotropin
UNIVERSITY PATENTS INC49 citations90
US4430326AFeb 7, 1984
Method of diminishing glucose levels resulting from endogenous glucagon
UNIVERSITY PATENTS INC6 citations54
COMPETITIVE TECH INC
3 patentsH LEE MOFFITT CANCER CT & RES
3 patentsUS12173087B2Dec 24, 2024
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations60
US11230568B2Jan 25, 2022
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations60
US10329326B2Jun 25, 2019
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations50